Singapore is a leader when it comes to digital trade and recent policy developments will open great opportunities, as well as paving the way for other countries to follow suit.
Cancer Genetics has merged with StemoniX and is addressing the challenges of drug discovery using innovative, science-based technologies and a highly-developed focus on the regulatory community.